Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Insulin Glargine

    Tag: Insulin Glargine

    You Searched For "insulin-glargine"
    Biocon gets USFDA EIR with VAI Classification for its Malaysian Insulin Manufacturing Facility

    Biocon gets USFDA EIR with VAI Classification for its Malaysian Insulin Manufacturing Facility

    Medical Dialogues Bureau1 April 2020 7:14 AM GMT
    Bengaluru: Biocon Sdn Bhd, a subsidiary of Biocon Limited has announced that it has received the Establishment Inspection Report (EIR) from the U.S. FD...
    Novo Nordisk Tresiba shows lower risk of hypo in adults with Type 2 Diabetes

    Novo Nordisk Tresiba shows lower risk of hypo in adults with Type 2 Diabetes

    Medical Dialogues Bureau21 Sep 2019 4:00 AM GMT
    'We are delighted that the findings of the CONCLUDE trial support what we have seen previously across the Tresiba clinical development programme,' said...
    Biocon, Mylan get European Commission approval to market biosimilar insulin glargine

    Biocon, Mylan get European Commission approval to market biosimilar insulin glargine

    Ruby Khatun Khatun30 March 2018 5:00 AM GMT
    New Delhi: Biotechnology major Biocon and Mylan said their co-developed biosimilar insulin glargine has received marketing authorization approval from ...

    Popular Stories

    • Email: info@medicaldialogues.in
    • Phone: 011 - 4372 0751

    Website Last Updated On : 27 May 2022 6:45 AM GMT
    Company
    • About Us
    • Contact Us
    • Our Team
    • Reach our Editor
    • Feedback
    • Submit Article
    Ads & Legal
    • Advertise
    • Advertise Policy
    • Terms and Conditions
    • Privacy Policy
    • Editorial Policy
    • Comments Policy
    • Disclamier

    This website is certified by Health On the Net Foundation. Click to verify. This site complies with the HONcode standard for trustworthy health information:
    verify here.

    Search only trustworthy HONcode health websites:

    Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

    Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2020 Minerva Medical Treatment Pvt Ltd

    © 2020 - Medical Dialogues. All Rights Reserved.
    Powered By: Hocalwire
    We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok
    X
    X